This week, Antidote announced $11 million in funding led by Merck Global Health Innovation Fund to accelerate our clinical trial matching platform. Our news as well as updates from several other clinical trial companies were featured in MedCity News:
"This week, Antidote Technologies raised $11 million in a Series A round for its clinical trial matching business led by Merck Global Health Innovation Fund and with participation from existing investors Smedvig Capital and Octopus Ventures.
...
The fundraise will help the business harness data from EHRs for its trial matching platform towards precision medicine."
Read more at MedCity News.
